Skip to Content
Merck
  • The Wilms' tumour suppressor Wt1 is a major regulator of tumour angiogenesis and progression.

The Wilms' tumour suppressor Wt1 is a major regulator of tumour angiogenesis and progression.

Nature communications (2014-12-17)
Kay-Dietrich Wagner, Julien Cherfils-Vicini, Naoki Hosen, Peter Hohenstein, Eric Gilson, Nicholas D Hastie, Jean-François Michiels, Nicole Wagner
ABSTRACT

Angiogenesis, activation of metastasis and avoidance of immune destruction are important for cancer progression. These biological capabilities are, apart from cancer cells, mediated by different cell types, including endothelial, haematopoietic progenitor and myeloid-derived suppressor cells. We show here that all these cell types frequently express the Wilms' tumour suppressor Wt1, which transcriptionally controls expression of Pecam-1 (CD31) and c-kit (CD117). Inducible conditional knockout of Wt1 in endothelial, haematopoietic and myeloid-derived suppressor cells is sufficient to cause regression of tumour vascularization and an enhanced immune response, leading to decreased metastasis, regression of established tumours and enhanced survival. Thus, Wt1 is an important regulator of cancer growth via modulation of tumour vascularization, immune response and metastasis formation.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
5(6)-Carboxyfluorescein diacetate N-succinimidyl ester, BioReagent, suitable for fluorescence, ≥90% (HPLC)
Supelco
Tamoxifen, analytical standard
Sigma-Aldrich
Tamoxifen, ≥99%
Sigma-Aldrich
Anti-acetyl-Histone H3 Antibody, from rabbit